REGN Retained Earnings

Regeneron Pharmaceuticals · Retained Earnings

REGN logo

REGN Retained Earnings

Latest reported$35.80B
REGN FY Retained Earnings (-$7.00M → $35.80B)
High-resolution chart · PNG

REGN retained earnings history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Retained Earnings — Annual fiscal periods (USD)
Period endingRetained Earnings (USD)
35,797,100,000
31,672,900,000
27,260,300,000
23,306,700,000
18,968,300,000
10,893,000,000
7,379,800,000
5,254,300,000
2,946,733,000
1,748,222,000
852,700,000
255,382,000
-92,692,000
-517,054,000
-1,267,323,000
-1,045,563,000
-941,095,000
-875,927,000
-793,217,000
-687,617,000
-585,280,000
-489,834,000
-531,533,000
-424,075,000
-299,698,000
-223,518,000
-200,300,000
-177,200,000
-168,600,000
-157,000,000
-124,600,000
-101,100,000
-70,400,000
-30,600,000
-11,400,000
-7,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.